Standard treatments for slow heart rate which include atropine administration and external pacing will not produce effective ...

Beta-blocker therapy after myocardial infarction (MI) failed to lower the rate of all-cause death, MI, or heart failure in patients with a left ventricular ejection fraction (LVEF) of at least 50%, ...

New Zealand has become the latest country to announce that it will halt new prescriptions for puberty blockers for young people with gender dysphoria. While young people who currently have a ...

Two controversial research studies assessing the risks and benefits of giving puberty blockers to young people with gender incongruence will go ahead.1 The trials received all necessary regulatory and ...

Puberty blockers for under-18s have been illegal in the UK since 2024 By Hannah Barnes A new research trial to study the impact of puberty blockers in children experiencing gender incongruence (a ...

Details of a new UK clinical trial to assess the risks and benefits of puberty-blocking drugs in children who question their gender have been announced. It follows the banning of the drugs for gender ...

WELLINGTON, New Zealand — New Zealand said Wednesday that it was banning new prescriptions of puberty blocking drugs for young transgender people, in a move that critics warned could worsen the mental ...

The New Zealand cabinet has signed off on plans to halt new prescriptions for puberty blockers for young people with gender dysphoria from mid-December. The imminent pause on puberty blockers has ...

Treatment with beta-blocker therapy did not reduce the incidence of all-cause death, myocardial infarction (MI) or heart failure (HF) in patients with a preserved LVEF (≥50%) after a recent MI, ...